0001209191-17-047492.txt : 20170803
0001209191-17-047492.hdr.sgml : 20170803
20170803181129
ACCESSION NUMBER: 0001209191-17-047492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170801
FILED AS OF DATE: 20170803
DATE AS OF CHANGE: 20170803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LUCAS ROGER C
CENTRAL INDEX KEY: 0000902080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 171006362
MAIL ADDRESS:
STREET 1: 41 EAST PLEASANT LAKE ROAD
CITY: NORTH OAKS
STATE: MN
ZIP: 55127
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-01
0
0001340652
ChemoCentryx, Inc.
CCXI
0000902080
LUCAS ROGER C
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2017-08-01
4
S
0
2250
10.0742
D
93846
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.95 to $10.17 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
2017-08-03